A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation

Stephen Andrew LaHaye; Sabra Lynn Gibbens; David Gerald Andrew Ball; Andrew George Day; Jonas Bjerring Olesen; Allan Cameron Skanes

doi:10.1093/eurheartj/ehs167

A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation

Stephen Andrew LaHaye, Sabra Lynn Gibbens, David Gerald Andrew Ball, Andrew George Day, Jonas Bjerring Olesen, Allan Cameron Skanes

44 Citations (Scopus)

Abstract

The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime for the prevention of stroke in patients who are newly diagnosed with non-valvular atrial fibrillation.

Original language	English
Journal	Eur.Heart J.
Volume	33
Issue number	17
Pages (from-to)	2163-71
Number of pages	9
ISSN	0195-668X
DOIs	https://doi.org/10.1093/eurheartj/ehs167
Publication status	Published - 2012

Access to Document

10.1093/eurheartj/ehs167

Cite this

@article{9689c2672b9641e19a65373119822fab,

title = "A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation",

abstract = "The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime for the prevention of stroke in patients who are newly diagnosed with non-valvular atrial fibrillation.",

author = "LaHaye, \{Stephen Andrew\} and Gibbens, \{Sabra Lynn\} and Ball, \{David Gerald Andrew\} and Day, \{Andrew George\} and Olesen, \{Jonas Bjerring\} and Skanes, \{Allan Cameron\}",

year = "2012",

doi = "10.1093/eurheartj/ehs167",

language = "English",

volume = "33",

pages = "2163--71",

journal = "Eur.Heart J.",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "17",

}

TY - JOUR

T1 - A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation

AU - LaHaye, Stephen Andrew

AU - Gibbens, Sabra Lynn

AU - Ball, David Gerald Andrew

AU - Day, Andrew George

AU - Olesen, Jonas Bjerring

AU - Skanes, Allan Cameron

PY - 2012

Y1 - 2012

N2 - The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime for the prevention of stroke in patients who are newly diagnosed with non-valvular atrial fibrillation.

AB - The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime for the prevention of stroke in patients who are newly diagnosed with non-valvular atrial fibrillation.

UR - https://www.scopus.com/pages/publications/84866088694

U2 - 10.1093/eurheartj/ehs167

DO - 10.1093/eurheartj/ehs167

M3 - Journal article

C2 - 22752615

SN - 0195-668X

VL - 33

SP - 2163

EP - 2171

JO - Eur.Heart J.

JF - Eur.Heart J.

IS - 17

ER -

A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation

Abstract

Access to Document

Other files and links

Fingerprint

Cite this